Patent Document ID: 9914972
Application ID: 14008276
Patent Status: 1

Claim One:
1. A method for classifying a lung cancer as a subtype selected from the group consisting of squamous cell carcinoma, non-squamous non-small cell lung cancer (NSCLC), carcinoid lung cancer, and small cell lung carcinoma, the method comprising: providing RNA obtained from a lung cancer sample from a human subject in need thereof; determining an expression profile of nucleic acid sequences comprising SEQ ID NOS: 1-8 in said lung cancer sample, wherein the expression profile is determined by nucleic acid amplification comprising contacting the RNA of said lung cancer sample with forward primers comprising SEQ ID NOs: ii and 12; using a classifier algorithm to compare said expression profile to a training data set comprising expression levels of SEQ ID NOs: 1-8 determined in diagnosed lung cancers from each of said lung cancer subtype; wherein the comparison of said expression profile to said training data set assigns said lung cancer sample to one of said subtypes of lung cancer; and classifying said lung cancer sample into one of said subtypes based on said comparison.